Clinical trial
Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia
NCT01324167 is registered in ClinicalTrials.gov with Taipei Medical University WanFang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia
- Lead sponsor
- Taipei Medical University WanFang Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 31, 2010
- Completion date
- April 30, 2011
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schizoaffective disorder, schizophrenia